Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.8270
-0.0050 (-0.60%)
At close: Jun 26, 2026, 4:00 PM EDT
0.8309
+0.0039 (0.47%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $12.53 million as of June 26, 2026. Its market cap has increased by 22.38% in one year.
Market Cap
12.53M
Enterprise Value
9.40M
1-Year Change
22.38%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $12.53M, a decrease of -96.94%. That is a compound annual growth rate of -23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 12.53M | 38.76% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 14.03M |
| Cocrystal Pharma | 13.93M |
| Passage Bio | 13.89M |
| Lexaria Bioscience | 13.73M |
| Cyclerion Therapeutics | 13.44M |
| BioVie | 13.42M |
| IN8bio | 13.39M |
| BioCardia | 12.40M |